Dr. Eitzman’s research focuses on the genetic determinants of thrombosis, atherosclerosis, and inflammation. His research in collaboration through the Michigan Medicine-Peking University Health Science Center Joint Institute explores how metabolic variations impact the effectiveness of antiplatelet therapies.
Daniel Eitzman, MD
Professor of Internal Medicine
Countries of Interest: China